High E-selectin-ligand expression, studied by percentage of binding to E-selectin-Fc chimeric protein and HECA452, in both AML blasts and LSC was associated with improved remission and survival with uproleselan treatment in those patients. The gene discussed is SELE; the disease is acute myeloid leukemia.